BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25269858)

  • 1. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.
    Sousa B; Ribeiro AS; Nobre AR; Lopes N; Martins D; Pinheiro C; Vieira AF; Albergaria A; Gerhard R; Schmitt F; Baltazar F; Paredes J
    BMC Cancer; 2014 Oct; 14():734. PubMed ID: 25269858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
    Chen CL; Chu JS; Su WC; Huang SC; Lee WY
    Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
    Choi J; Jung WH; Koo JS
    Pathobiology; 2013; 80(1):41-52. PubMed ID: 22832328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
    Vleugel MM; Shvarts D; van der Wall E; van Diest PJ
    Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
    Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
    Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
    Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB
    Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of metabolism-related proteins in phyllodes tumors.
    Kwon JE; Jung WH; Koo JS
    Tumour Biol; 2013 Feb; 34(1):115-24. PubMed ID: 22986897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
    Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrotic focus and hypoxia in male breast cancer.
    Kornegoor R; Verschuur-Maes AH; Buerger H; Hogenes MC; de Bruin PC; Oudejans JJ; Hinrichs B; van Diest PJ
    Mod Pathol; 2012 Oct; 25(10):1397-404. PubMed ID: 22684218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
    Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
    J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
    Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
    Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
    Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
    Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
    Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
    Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
    BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
    Dungwa JV; Hunt LP; Ramani P
    BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
    Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
    Cleven AH; van Engeland M; Wouters BG; de Bruïne AP
    Cell Oncol; 2007; 29(3):229-40. PubMed ID: 17452775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.